In vitro synergistic activity of the sulbactam/avibactam combination against extensively drug-resistant Acinetobacter baumannii

References

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538–582 [View Article][PubMed]
   [Google Scholar]
2. Rodríguez CH, Nastro M, Famiglietti A. Carbapenemases in Acinetobacter baumannii. Review of their dissemination in Latin America. Rev Argent Microbiol 2018; 50:327–333 [View Article][PubMed]
   [Google Scholar]
3. Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 2012; 67:1607–1615 [View Article][PubMed]
   [Google Scholar]
4. Karaiskos I, Lagou S, Pontikis K, Rapti V, Poulakou G. The "Old" and the "New" Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How. Front Public Health 2019; 7:151 [View Article][PubMed]
   [Google Scholar]
5. Piperaki E-T, Tzouvelekis LS, Miriagou V, Daikos GL. Carbapenem-Resistant Acinetobacter baumannii: in pursuit of an effective treatment. Clin Microbiol Infect 2019; 25:951–957 [View Article][PubMed]
   [Google Scholar]
6. Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother 2004; 48:1586–1592 [View Article][PubMed]
   [Google Scholar]
7. Yang Y, Xu Q, Li T, Fu Y, Shi Y et al. OXA-23 is a prevalent mechanism contributing to sulbactam resistance in diverse Acinetobacter baumannii clinical strains. Antimicrob Agents Chemother 2019; 63: [View Article][PubMed]
   [Google Scholar]
8. Mataracı Kara E, Yılmaz M, Özbek Çelik B. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates. J Glob Antimicrob Resist 2019; 17:137–141 [View Article][PubMed]
   [Google Scholar]
9. Álvarez-Buylla A, Culebras E, Picazo JJ. Identification of Acinetobacter species: is Bruker Biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques?. Infect Genet Evol 2012; 12:345–349 [View Article][PubMed]
   [Google Scholar]
10. Pournaras S, Gogou V, Giannouli M, Dimitroulia E, Dafopoulou K et al. Single-locus-sequence-based typing of bla _OXA-51-like genes for rapid assignment of Acinetobacter baumannii clinical isolates to international clonal lineages. J Clin Microbiol 2014; 52:1653–1657 [View Article][PubMed]
    [Google Scholar]
11. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii . Clin Microbiol Infect 2007; 13:807–815 [View Article][PubMed]
    [Google Scholar]
12. Rodríguez CH, Balderrama Yarhui N, Nastro M, Nuñez Quezada T, Castro Cañarte G et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in South America. J Med Microbiol 2016; 65:1088–1091 [View Article]
    [Google Scholar]
13. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27:351–353 [View Article][PubMed]
    [Google Scholar]
14. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011; 70:119–123 [View Article][PubMed]
    [Google Scholar]
15. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. Twenty-fifth Informational Supplement M100–S28 Wayne. PA: CLSI; 2018
    [Google Scholar]
16. Rodriguez CH, De Ambrosio A, Bajuk M, Spinozzi M, Nastro M et al. In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones. J Infect Dev Ctries 2010; 4:164–167 [View Article][PubMed]
    [Google Scholar]
17. Han M-L, Liu X, Velkov T, Lin Y-W, Zhu Y et al. Comparative metabolomics reveals key pathways associated with the synergistic killing of colistin and sulbactam combination against multidrug-resistant Acinetobacter baumannii . Front Pharmacol 2019; 10:754 [View Article][PubMed]
    [Google Scholar]